Proto Labs, Inc. logo PRLB - Proto Labs, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 5
HOLD 12
SELL 0
STRONG
SELL
0
| PRICE TARGET: $38.50 DETAILS
HIGH: $44.00
LOW: $34.00
MEDIAN: $37.50
CONSENSUS: $38.50
DOWNSIDE: 46.05%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 93.5% above fair value
Current Price $71.36
Bear Case $30.97 56.6% downside ($30.97 - $71.36) / $71.36 = -56.6% 4% stage 1 growth, 12% discount
Fair Value $36.88 48.3% downside ($36.88 - $71.36) / $71.36 = -48.3% 7% stage 1 growth, 12% discount
Bull Case $42.26 40.8% downside ($42.26 - $71.36) / $71.36 = -40.8% 9% stage 1 growth, 12% discount

Adjust Assumptions

7.3%
12.0%
3.0%

Key Value Driver

FCF growth rate (7% base case)

Terminal Value % of EV 32%
Implied Market Multiple 32.9x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $38.50 from 17 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $36.88 per share.

Warnings

Stock-based employee pay equals 74% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions